The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features

5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy

(2014) Marcel A. Kamp et al.   ACTA NEUROCHIRURGICA

5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma

(2013) Philippe Schucht et al.   ACTA NEUROCHIRURGICA

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010

(2013) Q. T. Ostrom et al.   NEURO-ONCOLOGY

Prognostic Value of Residual Fluorescent Tissue in Glioblastoma Patients After Gross Total Resection in 5-Aminolevulinic Acid-Guided Surgery

(2013) Guillermo Aldave et al.   NEUROSURGERY

5-Aminolevulinic Acid-derived Tumor Fluorescence

(2013) Walter Stummer et al.   NEUROSURGERY

5-Aminolevulinic Acid Induced Fluorescence Is a Powerful Intraoperative Marker for Precise Histopathological Grading of Gliomas with Non-Significant Contrast-Enhancement

(2013) Georg Widhalm et al.   PLoS One

Prognostic value of ventricular wall fluorescence during 5-aminolevulinic-guided surgery for glioblastoma

(2012) Sonia Tejada-Solís et al.   ACTA NEUROCHIRURGICA

Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin

(2012) S G M Piccirillo et al.   BRITISH JOURNAL OF CANCER

Gross Total Resection Rates in Contemporary Glioblastoma Surgery

(2012) Philippe Schucht et al.   NEUROSURGERY

Finding the anaplastic focus in diffuse gliomas: The value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence

(2011) Christian Ewelt et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Combined fluorescence and reflectance spectroscopy for in vivo quantification of cancer biomarkers in low- and high-grade glioma surgery

(2011) Pablo A. Valdés et al.   JOURNAL OF BIOMEDICAL OPTICS

Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas

(2011) Nader Sanai et al.   JOURNAL OF NEUROSURGERY

Fluorescence illuminates the way ...

(2011) R. Nishikawa   NEURO-ONCOLOGY

Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas

(2011) M. Kunz et al.   NEURO-ONCOLOGY

Comparison of 18F-FET PET and 5-ALA fluorescence in cerebral gliomas

(2010) Frank Willi Floeth et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience

(2010) Ricardo Díez Valle et al.   JOURNAL OF NEURO-ONCOLOGY

Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid–induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters

(2010) David W. Roberts et al.   JOURNAL OF NEUROSURGERY

Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas

(2009) Florian Stockhammer et al.   ACTA NEUROCHIRURGICA

Monoclonal antibody specific for IDH1 R132H mutation

(2009) David Capper et al.   ACTA NEUROPATHOLOGICA

Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients

(2009) J. Felsberg et al.   CLINICAL CANCER RESEARCH

FIVE-AMINOLEVULINIC ACID FOR FLUORESCENCE-GUIDED RESECTION OF RECURRENT MALIGNANT GLIOMAS

(2009) Arya Nabavi et al.   NEUROSURGERY

Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas

(2008) Justin S. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas

(2008) Florian Stockhammer et al.   JOURNAL OF NEURO-ONCOLOGY

Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients

(2008) Uwe Pichlmeier et al.   NEURO-ONCOLOGY

Prognostic significance of imaging contrast enhancement for WHO grade II gliomas

(2008) Johan Pallud et al.   NEURO-ONCOLOGY